BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36482633)

  • 21. Hepatectomy for hepatocellular carcinoma complicated by vasculitis flare.
    Abdi Z; Krasnokutsky S; Rapkiewicz A; Saxena A; Villanueva G; Sarpel U
    HPB Surg; 2010; 2010():841754. PubMed ID: 20862343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.
    Chen ZL; Yao LQ; Pu JL; Wu H; Xu XF; Chen TH; Zhou YH; Wang H; Chen ZY; Sun LY; Diao YK; Zhong JH; Lau WY; Pawlik TM; Huang DS; Shen F; Liang YJ; Yang T
    Eur J Surg Oncol; 2022 May; 48(5):1078-1086. PubMed ID: 34838392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Choi SB; Kim HJ; Song TJ; Ahn HS; Choi SY
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):639-47. PubMed ID: 24867654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopic Liver Resection for Hepatocellular Carcinoma in Child-Pugh A Patients With and Without Portal Hypertension: A Multicentre Study.
    Casellas-Robert M; Lim C; Lopez-Ben S; Lladó L; Salloum C; Codina-Font J; Comas-Cufí M; Ramos E; Figueras J; Azoulay D
    World J Surg; 2020 Nov; 44(11):3915-3922. PubMed ID: 32661688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
    Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
    Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: implications for the management of hepatocellular carcinoma eligible for liver transplantation.
    Chirica M; Tranchart H; Tan V; Faron M; Balladur P; Paye F
    Ann Surg Oncol; 2013 Jul; 20(7):2405-12. PubMed ID: 23338483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
    Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
    World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmental artificial neural network model to evaluate the preoperative safe limit of future liver remnant volume for HCC combined with clinically significant portal hypertension.
    Lu HZ; Mai RY; Wang XB; Chen J; Bai T; Ma L; Xiang BD; Cheng SQ; Guo WX; Li LQ; Ye JZ
    Future Oncol; 2022 Jul; 18(21):2683-2694. PubMed ID: 35699041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series.
    Sapisochin G; Bilbao I; Balsells J; Dopazo C; Caralt M; Lázaro JL; Castells L; Allende H; Charco R
    World J Surg; 2010 Sep; 34(9):2146-54. PubMed ID: 20411387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
    Wang X; Sun X; Lei Y; Pei J; Ma K; Feng K; Lau WY; Xia F
    J Invest Surg; 2023 Dec; 36(1):1-7. PubMed ID: 36345736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined operations for patients with hepatic cancer complicated by portal hypertension].
    Liu XG; Li CL; Lin JH; Liu ZJ; Yang JC
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1106-8. PubMed ID: 12480586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis.
    Tang YH; Zhu WJ; Wen TF
    Asian Pac J Cancer Prev; 2014; 15(4):1649-54. PubMed ID: 24641383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.
    Zhong JH; Li H; Xiao N; Ye XP; Ke Y; Wang YY; Ma L; Chen J; You XM; Zhang ZY; Lu SD; Li LQ
    PLoS One; 2014; 9(9):e108755. PubMed ID: 25268959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.
    Liu J; Zhang H; Xia Y; Yang T; Gao Y; Li J; Wu Y; Shen F
    HPB (Oxford); 2019 Jan; 21(1):1-13. PubMed ID: 30082213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy.
    Preda CM; Baicus C; Sandra I; Oproiu A; Manuc T; Constantinescu I; Gavrila D; Diculescu M; Dumitru R; Vasilescu C; Tieranu C; Istratescu D; Voiosu T; Manuc M
    United European Gastroenterol J; 2019 Jun; 7(5):699-708. PubMed ID: 31210948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 2002 Mar; 235(3):373-82. PubMed ID: 11882759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study.
    Zheng J; Feng X; Liang Y; Cai J; Shi Z; Kirih MA; Tao L; Liang X
    Surg Endosc; 2021 Jul; 35(7):3267-3278. PubMed ID: 32632488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.
    Zheng YW; Wang KP; Zhou JJ; Zhang ZQ; Xiong L; Wen Y; Zou H
    Scand J Gastroenterol; 2018 Dec; 53(12):1562-1568. PubMed ID: 30572742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Centrally located small unifocal hepatocellular carcinoma between minor conservative liver resection and major hepatectomy. Case reports.
    De Raffele E; Mirarchi M; Caserta CA; Cuicchi D; Pendino GM; Lecce F; Cariani S; Cola B
    Ann Ital Chir; 2018; 89():128-137. PubMed ID: 29848810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.